Sign In
Buy MTNB
$0.778
+0.0120 (+1.57%)
At Close: Jun 03, 2026
5 Penny Stocks To Buy According To Analysts With Targets Up To 156%
03:30pm, Tuesday, 16'th Nov 2021 PennyStocks
Penny stocks to buy right now according to analysts.
The post 5 Penny Stocks To Buy According To Analysts With Targets Up To 156% appeared first on Penny Stocks to Buy, Picks, News and Information | P
5 Penny Stocks To Buy According To Analysts With Targets Up To 156%
10:30am, Tuesday, 16'th Nov 2021
Penny stocks to buy right now according to analysts. The post 5 Penny Stocks To Buy According To Analysts With Targets Up To 156% appeared first on Penny Stocks to Buy, Picks, News and Information | P
Matinas BioPharma Holdings, Inc.'s (MTNB) CEO Jerome Jabbour on Q3 2021 Results - Earnings Call Transcript
12:48pm, Monday, 08'th Nov 2021
Matinas BioPharma Holdings, Inc.'s (MTNB) CEO Jerome Jabbour on Q3 2021 Results - Earnings Call Transcript
Matinas Biopharma Holdings, Inc. (MTNB) Reports Q3 Loss, Misses Revenue Estimates
09:14am, Monday, 08'th Nov 2021
Matinas Biopharma Holdings, Inc. (MTNB) delivered earnings and revenue surprises of 0.00% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead
5 Penny Stocks to Watch That Exploded Today, What You Need to Know
12:36pm, Thursday, 23'rd Sep 2021
These penny stocks exploded during today's trading session, are they worth watching or not? The post 5 Penny Stocks to Watch That Exploded Today, What You Need to Know appeared first on Penny Stocks t
Matinas BioPharma Announces Webcast of Presentation at the H.C. Wainwright Global Investment Conference
07:00am, Tuesday, 14'th Sep 2021
BEDMINSTER, N.J., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that Jerome D. Jabbour, Chief Executive Officer, presented a Company overview a
Matinas BioPharma Stock Jumps After Meningitis Candidate Data
08:36am, Monday, 13'th Sep 2021
Matinas BioPharma Holdings Inc (NYSE: MTNB) has announced positive data from the first two cohorts of the Phase 2 EnACT trial of MAT2203 (oral amphotericin B) for cryptococcal meningitis. The study
– Step-down therapy with MAT2203 achieved effective clearance of fungal organisms; Mean Early Fungicidal Activity (EFA) was 0.38, exceeding the prespecified primary endpoint threshold target of >0.2
Matinas BioPharma Announces Issuance of U.S. Patent Protecting MAT2203 to Treat or Prevent Cryptococcus Infections
07:00am, Monday, 16'th Aug 2021
Method-of-use patent strengthens and diversifies MAT2203's long-term patent portfolio Method-of-use patent strengthens and diversifies MAT2203's long-term patent portfolio
Matinas BioPharma Holdings, Inc. (MTNB) CEO Jerome Jabbour on Q2 2021 Results - Earnings Call Transcript
11:22am, Tuesday, 10'th Aug 2021
Matinas BioPharma Holdings, Inc. (MTNB) CEO Jerome Jabbour on Q2 2021 Results - Earnings Call Transcript
Matinas Biopharma Holdings, Inc. (MTNB) Reports Q2 Loss, Misses Revenue Estimates
09:22am, Tuesday, 10'th Aug 2021
Matinas Biopharma Holdings, Inc. (MTNB) delivered earnings and revenue surprises of 0.00% and -100.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for
Matinas BioPharma Reports Second Quarter 2021 Financial Results and Operational Highlights
06:31am, Tuesday, 10'th Aug 2021
– Enrollment complete in second cohort of EnACT study of MAT2203 (oral amphotericin B) in cryptococcal meningitis; Data and Safety Monitoring Board (DSMB) review of safety and efficacy data from sec
Matinas BioPharma to Participate in BTIG Virtual Biotechnology Conference
07:30am, Tuesday, 03'rd Aug 2021
BEDMINSTER, N.J., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that Jerome D. Jabbour, Chief Executive Officer, has been invited to participate
Matinas BioPharma to Webcast Conference Call Discussing Second Quarter 2021 Financial and Operational Results on August 10, 2021
07:00am, Tuesday, 27'th Jul 2021
BEDMINSTER, N.J., July 27, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of c
Best Penny Stocks To Buy? 4 To Watch This Week With Potential Catalysts
12:16pm, Sunday, 13'th Jun 2021
Penny stocks to watch with upcoming event dates to keep in mind this week The post Best Penny Stocks To Buy? 4 To Watch This Week With Potential Catalysts appeared first on Penny Stocks to Buy, Picks,
